Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events (U54)

Post Date

July 30th 2010

Application Due Date

September 30th 2010

Funding Opportunity Number

RFA-CI-11-001

CFDA Number(s)

93.283

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

4

Eligibility Categories

Other

Eligible Institutions You may submit an application(s) if your organization has any of the following characteristics: Public nonprofit organizations Private nonprofit organizations For profit organizations Small, minority, and women-owned businesses Universities Colleges Research institutions Hospitals Community-based organizations Faith-based organizations Federally recognized or state-recognized American Indian/Alaska Native tribal governments American Indian/Alaska Native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If you are applying as a bona fide agent of a state or local government, signed by the State/Local government and the agent, as documentation of your status you must provide a letter from the state or local government as documentation of your status

Funding

• Estimated Total Funding:

  $8000000

• Award Range:

  $0 - $2000000

Grant Description

The National Center Emerging and Zoonotic Infectious Diseases (NCEZID) of CDC within HHS is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010" and to measuring program performance as stipulated by the Government Performance and Review Act (GPRA). This RFA addresses “Healthy People 2010” priority area(s) of reduce hospital-acquired infections in intensive care unit patients, reduce central-line blood stream infections, and reduce the incidence of invasive methicillin-resistance staphylococcus aureus (MRSA) infections and is in alignment with NCEZID’s (proposed) performance goal(s) to protect Americans from infectious diseases. For more information, www.healthypeople.gov. and

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  Centers for Disease Control and Prevention
  Procurement and Grants Office
  TIMS
  Phone 770-488-2700

• Agency Mailing Address:

  PGOTIM@cdc.gov

• Agency Email Address:

  PGOTIM@cdc.gov

• Location:

  Centers for Disease Control and Prevention